A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review

@article{Almeida2014ASR,
  title={A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review},
  author={John R. de Almeida and James Kenneth Byrd and Rebecca Wu and Chaz L. Stucken and U. Duvvuri and David Paul Goldstein and Brett A Miles and Marita S. Teng and Vishal Gupta and Eric M Genden},
  journal={The Laryngoscope},
  year={2014},
  volume={124}
}
OBJECTIVES/HYPOTHESIS To demonstrate the comparative effectiveness of transoral robotic surgery (TORS) to intensity modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer. [] Key MethodDATA SOURCES The search included MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, and bibliographies of relevant studies through September 2012. METHODS Studies included patients treated for early T-stage oropharynx cancer with TORS or IMRT.

The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients

To assess adjuvant therapy in patients undergoing surgical management of oropharyngeal squamous cell carcinoma (OPSCCA) with transoral robotic surgery (TORS) and neck dissection.

Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes

Oncologic outcomes after transoral robotic surgery (TORS) ± adjuvant therapy for oropharyngeal squamous cell carcinoma (SCC) are presented.

Cost‐effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost‐utility analysis

An economic evaluation comparing transoral robotic surgery (TORS) to (chemo)radiotherapy for the management of early T‐classification oropharyngeal cancer is presented.

Primary transoral robotic surgery +/‐ adjuvant therapy for oropharyngeal squamous cell carcinoma—A large observational single‐centre series from the United Kingdom

  • J. O’HaraL. Warner V. Paleri
  • Medicine
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
  • 2021
These are the first reported oncological outcomes of Transoral Robotic Surgery for oropharyngeal squamous cell carcinoma in the UK and for selected patients, TORS with or without adjuvant therapy is an appropriate treatment modality.

Quality of life after radiation and transoral robotic surgery in advanced oropharyngeal cancer

A cross‐section of advanced stage OPSCC patients treated with multimodal therapies at the Survivorship Clinic was analyzed to investigate treatment factors associated with QOL.

Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer

To compare quality of life (QOL) of patients who underwent transoral robotic surgery (TORS) alone, with adjuvant radiation therapy (RT), or adjuvant chemoradiation therapy (CRT) in the treatment of

Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma

As transoral robotic surgery (TORS) is being increasingly used to treat patients with oropharyngeal squamous cell carcinoma (OPSCC), there is an interest in determining contributors to readmission.

Making a case for high‐volume robotic surgery centers: A cost‐effectiveness analysis of transoral robotic surgery

To evaluate the cost‐effectiveness of transoral robotic surgery (TORS) compared to intensity‐modulated radiotherapy (IMRT) for early stage (T1‐2, N0, M0) oropharyngeal squamous cell carcinoma (OPSCC).

A prospective evaluation of short‐term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx

Dysphagia in the perioperative period has been inadequately characterized and short‐term swallowing outcomes after TORS for OPSCC were characterized.

Treatments for locally advanced oropharyngeal cancer: A systematic review of clinical effectiveness and cost-effectiveness.

The superiority of primary surgery versus primary concurrent chemoradiotherapy (CRT) in the treatment of locally advanced oropharyngeal cancer (LAOPC) is not apparent and this system should be considered for further studies.
...

References

SHOWING 1-10 OF 37 REFERENCES

Transoral robotic resection and reconstruction for head and neck cancer

To evaluate the patterns of failure, survival, and functional outcomes for patients treated with transoral robotic surgery (TORS) and compare these results with those from a cohort of patients treating with concurrent chemoradiation (CRT), a large number of patients are treated with TORS.

Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16INK4a on treatment outcomes

To determine the prognostic influence of p16INK4a immunohistochemistry on the survival of resectable oropharyngeal carcinomas (OPSCC), a large number of patients were diagnosed with at least two types of cancer.

Concurrent neck dissection and transoral robotic surgery

1) Determine the incidence of pharyngocutaneous fistula associated with transoral robotic oropharyngectomy with concurrent neck dissection. 2) Discuss prevention and treatment of pharyngocutaneous

Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: A subset analysis of the university of pennsylvania transoral robotic surgery trial

The purpose of this study was to determine the regional recurrence rate of node‐positive oropharyngeal squamous cell carcinoma (OPSCC) in patients undergoing transoral robotic surgery (TORS) and

Preferences and utilities for health states after treatment for oropharyngeal cancer: Transoral robotic surgery versus definitive (chemo)radiotherapy

Treatment of oropharyngeal cancer with transoral robotic surgery (TORS) or definitive (chemo)radiotherapy impacts quality of life and economic comparisons.

Transoral robotic surgery and human papillomavirus status: Oncologic results

Assessment of HPV‐related outcomes after transoral robotic surgery (TORS) with adjuvant therapy as indicated found patients with oropharyngeal squamous cell carcinoma have distinct outcome profiles based on their human papillomavirus (HPV) status.

The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer

To investigate the impact of treatment modality and radiation technique on oncologic outcomes and toxicity of patients with locally advanced oropharyngeal cancer (OPC).

Intensity‐modulated radiotherapy for oropharyngeal squamous cell carcinoma 1

To report the outcomes after intensity‐modulated radiotherapy (IMRT) for patients with oropharyngeal squamous cell carcinoma.

Transoral robotic surgery for advanced oropharyngeal carcinoma.

This novel transoral robotic surgery treatment regimen offers disease control, survival, and safety commensurate with standard treatments and an unexpected beneficial outcome of gastrostomy dependency rates that are markedly lower than those reported with standard nonsurgical therapies.